Patients for Affordable Drugs Now advocates for the continuation of policies allowing Medicare to negotiate drug prices, while abortion rights supporters express concern over reproductive freedoms following the election results. Healthcare leaders anticipate regulatory changes under the new administration, particularly regarding AI and telehealth, as HIMSS emphasizes the need for Congress to act to maintain pandemic-related flexibilities. Pharmaceutical companies expect favorable conditions, while concerns about healthcare affordability and potential rollbacks of the Affordable Care Act loom, particularly for marginalized communities.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
